Verma Deepti, Lerm Maria, Blomgran Julinder Robert, Eriksson Per, Söderkvist Peter, Särndahl Eva
Linköping University, Linköping, Sweden.
Arthritis Rheum. 2008 Mar;58(3):888-94. doi: 10.1002/art.23286.
NALP3, ASC, and TUCAN are components of the NALP3 inflammasome, which triggers caspase 1-mediated interleukin-1beta (IL-1beta) release. Activating mutations in the gene encoding NALP3 (NLRP3) have recently been linked to familial periodic fever syndromes. We undertook this study to determine whether a patient with arthritis and antibiotic-resistant fever carried mutations in the genes encoding the NALP3 inflammasome.
Genetic analysis of NLRP3 and the gene encoding TUCAN (CARD-8) was performed on genomic DNA from the patient and from a population-based collection of DNA (806 subjects). For in vitro studies of IL-1beta production and caspase 1 activity, blood was obtained from the patient at different time points after administration of anakinra, an IL-1 receptor antagonist, as well as from 5 healthy age- and sex-matched control subjects.
Mutation analysis of the patient's genes encoding NALP3, ASC, and TUCAN revealed variations in the NLRP3 (Q705K) and CARD-8 (C10X) genes. The allele frequencies of these single-nucleotide polymorphisms (SNPs) in the population were 6.5% and 34%, respectively. The elevated activity of caspase 1 and the high levels of IL-1beta measured in samples from the patient returned to normal levels after treatment with anakinra.
Our results indicate that the patient's symptoms were due to elevated levels of IL-1beta, since treatment with anakinra effectively abolished the symptoms. The compound SNPs may explain the increased IL-1beta levels and inflammatory symptoms observed, but further studies are needed to reveal a functional relationship. The prevalence of the polymorphisms (4% of the population carry both SNPs) in the general population may suggest a genetic predisposition for common inflammatory disorders.
NALP3、ASC和TUCAN是NALP3炎性小体的组成成分,可触发半胱天冬酶1介导的白细胞介素-1β(IL-1β)释放。最近,编码NALP3(NLRP3)的基因中的激活突变与家族性周期性发热综合征有关。我们进行这项研究以确定一名患有关节炎和抗生素耐药性发热的患者在编码NALP3炎性小体的基因中是否携带突变。
对该患者以及基于人群收集的DNA(806名受试者)的基因组DNA进行NLRP3和编码TUCAN的基因(CARD-8)的遗传分析。为了进行IL-1β产生和半胱天冬酶1活性的体外研究,在给予IL-1受体拮抗剂阿那白滞素后的不同时间点从该患者以及5名年龄和性别匹配的健康对照受试者获取血液。
对该患者编码NALP3、ASC和TUCAN的基因进行突变分析,发现NLRP3(Q705K)和CARD-8(C10X)基因存在变异。这些单核苷酸多态性(SNP)在人群中的等位基因频率分别为6.5%和34%。用阿那白滞素治疗后,患者样本中测得的半胱天冬酶1活性升高和IL-1β高水平恢复到正常水平。
我们的结果表明,患者的症状是由于IL-1β水平升高所致,因为用阿那白滞素治疗有效地消除了症状。复合SNP可能解释了观察到的IL-1β水平升高和炎症症状,但需要进一步研究以揭示功能关系。这些多态性在普通人群中的患病率(4%的人群同时携带这两种SNP)可能提示常见炎症性疾病的遗传易感性。